PMFA
KITE

Plante Moran Financial Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Plante Moran Financial Advisors’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-8
Closed – – 1122
2015
Q4 		$0 Buy
+8
New +$563 ﹤0.01% 1024

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Plante Moran Financial Advisors's KITE Position: Q1 2016 in Review

Plante Moran Financial Advisors sold out of Kite Pharma, Inc. (KITE) in Q1 2016, closing a stake of 8 shares.

Plante Moran Financial Advisors first reported a position in KITE in Q4 2015 and held it in 1 quarter. The position peaked at $0 in Q4 2015. 171 funds tracked by Wall St. Rank hold KITE as of Q1 2016.

  • Plante Moran Financial Advisors reported no remaining Kite Pharma, Inc. position as of Q1 2016 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 8 Kite Pharma, Inc. shares in Q1 2016.
  • Plante Moran Financial Advisors first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 1 quarter.
  • Plante Moran Financial Advisors's Kite Pharma, Inc. position peaked at $0 in Q4 2015.
  • 171 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2016.

Based on Plante Moran Financial Advisors's 13F filing for Q1 2016, filed 26 Apr 2016.